Net sales for Q1 2026 were $2.4 million, a 26.2% increase compared to $1.9 million in Q1 2025. Gross profit improved to $1.7 million (70.1% margin) from $1.1 million (56.0% margin) in the prior year period. Net loss for the quarter was $4.5 million, compared to a net loss of $3.0 million in Q1 2025. Operating expenses increased to $6.3 million from $4.1 million, driven by R&D investments and the Rendiatech acquisition. Cash and cash equivalents were $2.1 million as of March 31, 2026, up from $1.1 million at year-end 2025.